Kate Therapeutics
Electric beach car with customizable design and zero-emission powertrain
- Sector
- Biotech
- Headquarters
- SAN DIEGO, CA
- Founded
- 2020
- Latest Form D
- $16M, Aug 2024
- Total capital
- $72.8M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $72.8M
- 3 Form D · last Aug 2024
- 27 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 40 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$16M
- Private capital raisedForm D · SEC · 2nd filing$35M
- Private capital raisedForm D · SEC · 1st filing$21.8M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Beth Seidenberg, M.D.DirectorNamed in SEC Form D filings
- Clare Ozawa, Ph.D.DirectorNamed in SEC Form D filings
- Kevin Forrest, Ph.D.Executive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 40- PendingAdeno-associated Virus Compositions For The Treatment Of Facioscapulohumeral Muscular DystrophyUSPTOApplication 19643597
- PendingLiver Detargeted CapsidsUSPTOApplication 19406703
- PendingCompositions For Treating XlmtmUSPTOApplication 18868544
Show all 40 patent records
- Adeno-associated Virus Compositions For The Treatment Of Facioscapulohumeral Muscular DystrophySep 17, 2026 · Application 19643597Pending
- Liver Detargeted CapsidsJun 18, 2026 · Application 19406703Pending
- Compositions For Treating XlmtmJan 8, 2026 · Application 18868544Pending
- Adeno-associated Virus Compositions For The Treatment Of Duchenne Muscular DystrophySep 4, 2025 · Application 19069995Pending
- Compositions And Methods For Muscle DisordersAug 7, 2025 · Application 18854776Pending
- Compositions And Methods For Muscle DisordersApplication PCTUS2025036162Pending
- Expression Control By Drg-expressed MirnasApplication PCTUS2025026016Pending
- Gene Therapy Approach For Treating Disorders Associated With TNNT2Application PCTUS2025026015Pending
- Adeno-associated Virus Compositions For The Treatment Of Facioscapulohumeral Muscular DystrophyApplication 63788362Pending
- Adeno-associated Virus Compositions For The Treatment Of Duchenne Muscular DystrophyApplication PCTUS2025018343Pending
- Compositions And Methods For Muscle DisordersApplication PCTUS2024051023Pending
- Liver Detargeted CapsidsApplication PCTUS2024044341Pending
- Liver De-targeted Muscle Tropic CapsidsApplication 63688379Pending
- Adeno-associated Virus Compositions For The Treatment Of Duchenne Muscular DystrophyApplication 63688024Pending
- Adeno-associated Virus Compositions For The Treatment Of Limb Girdle Muscular Dystrophy 2AApplication 63687987Pending
- Adeno-associated Virus Compositions For The Treatment Of Facioscapulohumeral Muscular DystrophyApplication 63687992Pending
- Adeno-associated Virus Compositions For The Treatment Of Limb Girdle Muscular Dystrophy 2AApplication 63677141Pending
- Adeno-associated Virus Compositions For The Treatment Of Duchenne Muscular DystrophyApplication 63676780Pending
- Adeno-associated Virus Compositions For The Treatment Of Facioscapulohumeral Muscular DystrophyApplication 63676790Pending
- Aav Gene Therapy Approach For Treating LGMD2B/DYSFERLINOPATHYApplication PCTUS2024037366Pending
- Compositions And Methods For Muscle DisordersApplication 63666905Pending
- Expression Control By Skeletal Muscle-expressed MirnasApplication 63666892Pending
- Muscle Targeting CapsidsApplication 19155100Pending
- Liver Detargeted CapsidsApplication 19146477Pending
- Codon Optimized Cargo For Dmd Field Of DisclosureApplication 63666899Pending
- Liver Detargeted CapsidsApplication 63644785Pending
- Compositions And Methods For Muscle DisordersApplication 63643138Pending
- Gene Therapy Approach For Treating Disorders Associated With TNNT2Application 63638086Pending
- Expression Control By Drg-expressed MirnasApplication 63638126Pending
- Aav Therapeutics For DmdApplication 63561130Pending
- Muscle Targeted CapsidsApplication PCTUS2024015200Pending
- Liver Targeted CapsidsApplication PCTUS2024010859Pending
- Compositions And Methods For Muscle DisordersApplication 63543708Pending
- Liver Detargeted CapsidsApplication 63585343Pending
- Aav Gene Therapy Approach For Treating LGMD2B/DYSFERLINOPATHYApplication 63525819Pending
- Compositions For Treating XlmtmApplication PCTUS2023066865Pending
- Compositions And Methods For Muscle DisordersApplication PCTUS2023065520Pending
- Muscle Targeting CapsidsApplication 63444416Pending
- Liver Targeted CapsidApplication 63444413Pending
- Liver Detargeted CapsidApplication 63437886Pending
Related companies, and why
- SepternaSimilar federal contract value in Biotech · null in contracts
- Blueprint MedicinesSimilar federal contract value in Biotech · null in contracts
- Spark Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Phosplatin Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
- MYDNA, INCSimilar federal contract value in Biotech · null in contracts
- Nucleus Radiopharma, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .